Clinical trial
A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric…
NCT00207675 · Centocor, Inc., Industry · Completed
Key facts
| NCT number | NCT00207675 |
|---|---|
| Title | A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease |
| Official title | A Randomized, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of Anti-TNF a Chimeric Monoclonal Antibody (Infliximab, REMICADE) in Pediatric Subjects With Moderate to Severe CROHN'S Disease. |
| Lead sponsor | Centocor, Inc., Industry |
| Collaborators | Centocor BV Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Crohn Disease |
| Intervention type | Drug |
| Interventions | infliximab |
| Enrollment | 112 |
| Start date | Feb 1, 2003 |
| Completion | Aug 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | May 17, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: